14 October 2022, Tring, UK: SCi Partners, the specialist boutique life science search and interim management partnership, is delighted to have joined One Nucleus.
SCi Partners comprises a highly regarded team of recruitment professionals with a rich heritage in biotech and life sciences, with particular emphasis on leading edge, early-stage, high growth organisations.
The partnership has recently rebranded from Horton International (UK), enabling it to focus on its core business within the life science industry.
Over the last two years, the team has grown rapidly, listening, and…
Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
HEADLINE RESULTS FROM PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE AT247 DEMONSTRATE SIGNIFICANTLY ACCELERATED INSULIN ABSORPTION AND EARLY EXPOSURE COMPARED TO GOLD STANDARD INSULINS NOVOLOG® AND FIASP®
- AT247 delivers significantly accelerated insulin absorption and early exposure (PK profile) compared with NovoLog® and Fiasp®, meeting co-primary endpoint
- AT247 delivers a statistically significant superior glucose lowering effect compared with NovoLog® supporting the accelerated absorption and early…
7th Oct 2022, New Delhi: Thermo Fisher Scientific, the world leader in serving science, recently participated in a conference on the Application of New-age Technologies in Diagnostics organized by the Confederation of Indian Industry (CII) Northern Regional Committee on Diagnostics and Technology.
CII is a non-government, not-for-profit, industry-led organization, that is engaged in creating and sustaining an environment conducive to the development of India.
Aimed at highlighting the present and future of diagnostics, in a lead-up to India’s 100th year of independence, the conference brought…
For 2022 only the Oncology Conference and the Precision Medicine Conference will both run in conjunction with each other. Join Bionow, expert speakers and industry colleagues to discuss the current oncology landscape and the future of precision medicine.
The prevention of cancer and the development of more effective strategies for early-stage detection, when treatment may be most effective, remain critical societal goals. Precision medicine is the next generation of healthcare research that has the potential to provide significant, targeted benefits to patients, and affect strategic shifts in…
DIVERSA is your One Nucleus member expert in drug delivery systems and pharmaceutical technology. DIVERSA is a spin-off of the Health Research Institute of Santiago de Compostela (IDIS) and the Servizo Galego de Saúde (SERGAS) established in January 2022. We have a global vocation to enable innovative therapies get to the clinic and the patients.
In line with its internationalization efforts, DIVERSA has been selected under the ICEX NEXT program on a competitive basis amongst more than 150 Spanish SMEs. There are two main reasons, we have been granted this chance:
1. DIVERSA meets the…
Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the addition of Avian products supporting vaccine manufacturing and virus research to the BioIVT Digital Portal through a global collaboration with the Avian Vaccine Services division of Charles River Laboratories International, Inc. (CRL). This agreement will benefit the research, diagnostic and manufacturing…
• Two new companies, Neobe Therapeutics and Genenet Technology, have been awarded space in the Lab Hotel
• The Lab Hotel provides free laboratory and office accommodation for start-up companies for six months
• Companies in the Lab Hotel have access to scientific and business support while they develop their innovations and secure their next round of funding.
Stevenage Bioscience Catalyst (SBC) has awarded space in its Lab Hotel to start-ups Neobe Therapeutics and Genenet Technology. The Lab Hotel is a unique facility offering free lab and office accommodation for six months. The facility is…
● BioMed Realty and Babraham Research Campus Ltd to deliver 40,000 square foot building through a new joint venture
● This development represents BioMed’s investment in its third building on the Campus and provides much needed space for scale-ups in the Cambridge, UK market
● The joint venture anticipates investing an additional £26 million to develop this facility over time and expects to support nearly 265 new local construction jobs
● The new building will incorporate fitted lab and office suites designed for flexibility to…
Press release
Professor Jeffrey Pollard Macomics’ Co-founding Board Member and Chair of its SAB Elected to the Academia Europaea
Edinburgh and Cambridge, UK, 03 October 2022 - Macomics Ltd, a biotech company with world-leading expertise in macrophage biology, congratulates its co-founder Prof. Jeffery Pollard Ph.D. on his election to the Academia Europaea (the European Academy, AE).
Prof. Pollard will be welcomed as a new at a ceremony during the 33rd Annual Conference of Academia Europaea, Building Bridges 2022, in Barcelona 27-27 October.
The prestigious Academia Europaea has recognized…